Status:
COMPLETED
Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor
Lead Sponsor:
Thomas Jefferson University
Conditions:
Malignant Solid Neoplasm
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This trial studies how well pharmacist-led transitions of care works in the outpatient oncology infusion center for patients with solid tumor. Having a pharmacist in the outpatient oncology infusion c...
Detailed Description
PRIMARY OBJECTIVE: I. To demonstrate the effectiveness of a clinical oncology pharmacist in the outpatient infusion center through education, and the identification and correction of medication relat...
Eligibility Criteria
Inclusion
- Solid tumor diagnosis
- Starting day 1 of new antineoplastic infusion
- English speaking (and/or English-speaking primary caregiver/proxy)
Exclusion
- Metastasis to the brain and/or central nervous system (CNS) with evidence of impaired cognition
- Severe cognitive impairment including dementia with inability to consent to the study
Key Trial Info
Start Date :
September 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 5 2021
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04122118
Start Date
September 25 2019
End Date
March 5 2021
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107